Literature DB >> 7844553

Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease.

J C Fox1, I M Kidd, P D Griffiths, P Sweny, V C Emery.   

Abstract

Serial surveillance samples of urine collected from 103 renal transplant recipients were analysed by polymerase chain reaction (PCR) for the presence of human cytomegalovirus (HCMV) DNA. The PCR results were consistently negative in 70 patients, none of whom developed HCMV disease, and PCR positive in 33 patients of whom 10 developed HCMV disease (P < 0.001). In 12 patients, PCR results were positive in three or more consecutive samples indicating extensive HCMV replication. HCMV load in 104 samples from these patients was analysed using a quantitative co-amplification PCR system. The maximal viral burden in the symptomatic patients ranged from 10(5.9) to 10(7.12) genomes/ml urine (median 10(6.5)) and in the asymptomatic patients from 10(4) to 10(5.7) genomes/ml urine (median 10(5.2)). The 10(1.3) difference between these median values was significant (P < 0.01). Individual kinetic profiles of viral burden showed that high levels of HCMV correlated with clinically apparent disease. In the majority of the asymptomatic individuals HCMV load remained between 10(4) and 10(5.1) genomes/ml urine; however, in two patients fluctuations in viral load were observed involving higher viral levels (up to 10(5.7) genomes/ml urine) suggesting that immune responses able to modulate viral replication could be studied in individual patients. Analysis of the temporal appearance and quantity of HCMV in the urine with alterations in white cell numbers showed that leukopenia occurred following the appearance of HCMV in the urine of symptomatic patients but preceded HCMV in the urine of asymptomatic patients (P = 0.01). Overall, these results show that longitudinal analysis using fully quantitative PCR methods for HCMV can provide insight into the natural history of HCMV disease in renal transplant recipients.

Entities:  

Mesh:

Year:  1995        PMID: 7844553     DOI: 10.1099/0022-1317-76-2-309

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation.

Authors:  C Aitken; W Barrett-Muir; C Millar; K Templeton; J Thomas; F Sheridan; D Jeffries; M Yaqoob; J Breuer
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation.

Authors:  C Y Tong; L E Cuevas; H Williams; A Bakran
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 3.  Quantitative molecular virology in patient management.

Authors:  W Preiser; B Elzinger; N S Brink
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

4.  LightCycler-based quantitative PCR for detection of cytomegalovirus in blood, urine, and respiratory samples.

Authors:  A M Kearns; B Draper; W Wipat; A J Turner; J Wheeler; R Freeman; J Harwood; F K Gould; J H Dark
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry.

Authors:  Roy F Chemaly; Belinda Yen-Lieberman; Elias A Castilla; Amy Reilly; Susana Arrigain; Carol Farver; Robin K Avery; Steven M Gordon; Gary W Procop
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

Authors:  Roland R Regoes; E Frances Bowen; Alethea V Cope; Dehila Gor; Aycan F Hassan-Walker; H Grant Prentice; Margaret A Johnson; Paul Sweny; Andrew K Burroughs; Paul D Griffiths; Sebastian Bonhoeffer; Vincent C Emery
Journal:  Proc Biol Sci       Date:  2006-08-07       Impact factor: 5.349

7.  Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients.

Authors:  M D Pescovitz; J Rabkin; R M Merion; C V Paya; J Pirsch; R B Freeman; J O'Grady; C Robinson; Z To; K Wren; L Banken; W Buhles; F Brown
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 8.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 9.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.

Authors:  W Y Barrett-Muir; C Aitken; K Templeton; M Raftery; S M Kelsey; J Breuer
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.